Role of radiation therapy in patients with a diagnosis of both systemic lupus erythematosus and cancer

Arthritis Care and Research

Volumn 53, Issue 1, 2005, Pages 67-72

  Benk, Véronique ^a   Al Herz, Adeeba ^b   Gladman, Dafna ^b   Urowitz, Murray ^b   Fortin, Paul R ^b  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Lupus; Radiotherapy; Toxicity

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; BREAST CANCER; CANADA; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISEASE ACTIVITY; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; LUNG CANCER; LYMPHOMA; MALE; OVARY CANCER; PROSPECTIVE STUDY; RADIATION DERMATITIS; RADIATION INJURY; REVIEW; SKIN CANCER; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOMA; MALE; MELANOMA; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIOTHERAPY; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 13444249493     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20912     Document Type: Review

References (34)

1. Bongu A, Chang E, Ramsey-Goldman R. Can morbidity and mortality of SLE be improved? Best Pract Res Clin Rheumatol 2002;16:313-32.
2. Bernatsky S, Boivin JF, Joseph L, St. Pierre Y, Moore A, Rajan R, et al. Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity. J Rheumatol 2002;29:2551-4.
3. Abu-Shakra M, Gladman DD, Urowitz MB. Malignancy in systemic lupus erythematosus. Arthritis Rheum 1996;39: 1050-4.
4. Bjornadal L, Lofstrom B, Yin L, Lundberg IE, Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002;31: 66-71.
5. Frankish H. 15 million new cancer cases per year by 2020, says WHO. Lancet 2003;361:1278.
6. Marrett LD, Frood J, Nishri D, Ugnat AM, Cancer in Young Adults in Canada (CYAC) Working Group. Cancer incidence in young adults in Canada: preliminary results of a cancer surveillance project. Chronic Dis Can 2002;23:58-64.
7. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
8. Wingo PA, Cardinez CJ, Landis SH, Greenlee RT, Ries LA, Anderson RN, et al. Long-term trends in cancer mortality in the United States: 1930-1998. Cancer 2003;97 Suppl:3133-275.
9. Mackillop WJ, Fu H, Quirt CF, Dixon P, Brundage M, Zhou Y. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 1994;30:221-8.
10. Winchester DP, Cox JD, and the American College of Radiology, American College of Surgeons, College of American Pathologists, Society of Surgical Oncology. Standards for diagnosis and management of invasive breast carcinoma. CA Cancer J Clin 1998;48:83-107.
11. Mayr NA, Riggs CE Jr, Saag KG, Wen BC, Pennington EC, Hussey DH. Mixed connective tissue disease and radiation toxicity: a case report. Cancer 1997;79:612-8.
12. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29; 288-91.
13. Ibanez D, Urowitz MD, Gladman DD. Summarizing disease features over time. I. Adjusted mean SLEDAI derivation and application to index of disease activity in lupus. J Rheumatol 2003;30:1977-82.
14. International Union Against Cancer. TNM classification of malignant tumors. Sobin L, Wittekind C, editors. 5th ed. New York: Wiley-Liss; 1997.
15. Sawka C, Olivotto I, Coldman A, Goel V, Holowaty E, Hislop TG, and the British Columbia/Ontario Working Group. The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer. Br J Cancer 1997;75:1534-42.
16. Chen AM, Obedian E, Haffty BG. Breast-conserving therapy in the setting of collagen vascular disease. Cancer J 2001;7:480-91.
17. Ross JG, Hussey DH, Mayr NA, Davis CS. Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer 1993;71:3744-52.
18. De Naeyer B, de Meerleer G, Braems S, Vakaet L, Huys J. Collagen vascular diseases and radiation therapy: a critical review. Int J Radiat Oncol Biol Phys 1999;44:975-80.
19. Fleck R, McNeese MD, Ellerbroek NA, Hunter TA, Holmes FA. Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int J Radiat Oncol Biol Phys 1989;17:829-33.
20. Morris MM, Powell SN. Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol 1997;15:2728-35.
21. Rakfal SM, Deutsch M. Radiotherapy for malignancies associated with lupus: case reports of acute and late reactions. Am J Clin Oncol 1998;21:54-7.
22. Olivotto IA, Fairey RN, Gillies JH, Stein H. Fatal outcome of pelvic radiotherapy for carcinoma of the cervix in a patient with systemic lupus erythematosis. Clin Radiol 1989;40: 83-4.
23. Rathmell AJ, Taylor RE. Enhanced normal tissue response to radiation in a patient with discoid lupus erythematosus. Clin Oncol (R Coll Radiol) 1992;4:331-2.
24. Urtasun RC. A complication of the use of radiation for malignant neoplasia in chronic discoid lupus erythematosus. J Can Assoc Radiol 1971;22:168-9.
25. Bentzen SM, Overgaard J. Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Semin Radiat Oncol 1994;4:68-80.
26. Chon BH, Loeffler JS. The effect of nonmalignant systemic disease on tolerance to radiation therapy. Oncologist 2002;7: 136-43.
27. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer and the Canadian Association of Radiation Oncologists. Breast radiotherapy after breast-conserving surgery. CMAJ 1998;158 Suppl 3:S35-42.
28. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med 1995;333:1444-55.
29. Fisher J, Scott C, Stevens R, Marconi B, Champion L, Freedman GM, et al. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 2000;48:1307-10.
30. Olivotto IA, Kim-Sing C, Bajdik CD, Trevisan CH, Ludgate CM, Weir LM, et al. Effect of acetylsalicylic acid on radiation and cosmetic results after conservative surgery for early breast cancer: a randomized trial. Radiother Oncol 1996;41:1-6.
31. Szumacher E, Wighton A, Franssen E, Chow E, Tsao M, Ackerman I, et al. Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. Int J Radiat Oncol Biol Phys 2001;51:81-6.
32. Olivotto IA, Weir LM, Kim-Sing C, Bajdik CD, Trevisan CH, Doll CM, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol 1996;41:7-13.
33. Eedy DJ, Corbett JR. Discoid lupus erythematosus exacerbated by x-ray irradiation. Clin Exp Dermatol 1988;13:202-3.
34. Balabanova MB, Botev IN, Michailova JI. Subacute cutaneous lupus erythematosus induced by radiation therapy. Br J Dermatol 1997;137:648-9.